Mark E. Erwin
Vorstandsvorsitzender bei Continental Micronesia, Inc.
Profil
Mark E.
Erwin currently works at Continental Micronesia, Inc., as President & Chief Executive Officer and Compañía Panameña de Aviación SA, as Director from 2004.
Mr. Erwin also formerly worked at Ligand Pharmaceuticals, Inc., as Director-Oncology Marketing from 2003 to 2005, Copa Holdings SA, as Director, Centric Health Finance LLC, as Senior Director-Program Development from 2005 to 2007, Continental Airlines, Inc., as SVP-Corporate Development & Alliances from 2009 to 2013, Eli Lilly & Co., as Product Manager-Oncology Business, Mast Therapeutics, Inc., as Senior Vice President-Operations, and IDEC Pharmaceuticals Corp., as Head-Government Affairs & Reimbursement from 1999 to 2003.
Mr. Erwin received his undergraduate degree from Purdue University.
Aktive Positionen von Mark E. Erwin
| Unternehmen | Position | Beginn |
|---|---|---|
Compañía Panameña de Aviación SA
 Compañía Panameña de Aviación SA AirlinesTransportation Cia Panameña de Aviación SA provides airline services. It operates daily scheduled flights to 30 destinations in 20 countries in North, Central, and South America, as well as in the Caribbean. The company also provides passengers with access to flights to more than 120 international destinations through code share agreements with Continental Airlines and other airlines. It was founded on August 15, 1947 and is headquartered in Panama City, Panama. | Direktor/Vorstandsmitglied | 01.01.2004 |
Continental Micronesia, Inc.
 Continental Micronesia, Inc. AirlinesTransportation Continental Micronesia, Inc. provides air transportation services. It also provides transporting passengers, cargo and mail in the Western Pacific. The company serves more than 23 cities in Pacific Rim, Micronesian Islands, and Hawaii. Continental Micronesia was founded in 1968 and is headquartered in Tamuning, Guam. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Mark E. Erwin
| Unternehmen | Position | Ende |
|---|---|---|
| CONTINENTAL AIRLINES, INC. | Corporate Officer/Principal | 15.10.2013 |
Centric Health Finance LLC
 Centric Health Finance LLC Miscellaneous Commercial ServicesCommercial Services Centric Health Finance LLC provides outsourcing services in the fields of healthcare, pharmaceuticals, and medical devices under the VirtualPayor trade name. The company was founded on May 30, 2006 and is headquartered in Indianapolis, IN. | Corporate Officer/Principal | 01.10.2007 |
| LIGAND PHARMACEUTICALS INCORPORATED | Vertrieb & Marketing | 01.06.2005 |
IDEC Pharmaceuticals Corp.
 IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | General Counsel | 01.10.2003 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Ausbildung von Mark E. Erwin
| Purdue University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| COPA HOLDINGS, S.A. | Transportation |
| LIGAND PHARMACEUTICALS INCORPORATED | Health Technology |
| ELI LILLY AND COMPANY | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Continental Airlines, Inc.
 Continental Airlines, Inc. AirlinesTransportation Continental Airlines, Inc. is an air carrier engaged in the business of transporting passengers, cargo and mail. The company operates in two business segments: mainline and regional. Continental Airlines was founded on July 15, 1934 and is headquartered in Houston, TX. | Transportation |
Compañía Panameña de Aviación SA
Compañía Panameña de Aviación SA AirlinesTransportation Cia Panameña de Aviación SA provides airline services. It operates daily scheduled flights to 30 destinations in 20 countries in North, Central, and South America, as well as in the Caribbean. The company also provides passengers with access to flights to more than 120 international destinations through code share agreements with Continental Airlines and other airlines. It was founded on August 15, 1947 and is headquartered in Panama City, Panama. | Transportation |
Mast Therapeutics, Inc.
 Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | Health Technology |
Continental Micronesia, Inc.
Continental Micronesia, Inc. AirlinesTransportation Continental Micronesia, Inc. provides air transportation services. It also provides transporting passengers, cargo and mail in the Western Pacific. The company serves more than 23 cities in Pacific Rim, Micronesian Islands, and Hawaii. Continental Micronesia was founded in 1968 and is headquartered in Tamuning, Guam. | Transportation |
Centric Health Finance LLC
Centric Health Finance LLC Miscellaneous Commercial ServicesCommercial Services Centric Health Finance LLC provides outsourcing services in the fields of healthcare, pharmaceuticals, and medical devices under the VirtualPayor trade name. The company was founded on May 30, 2006 and is headquartered in Indianapolis, IN. | Commercial Services |
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | Health Technology |
